We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.3B
AUM Growth
+$229M
Cap. Flow
-$342M
Cap. Flow %
-2.78%
Top 10 Hldgs %
11.52%
Holding
627
New
166
Increased
116
Reduced
155
Closed
161

Sector Composition

Rank Sector Weight
1 Technology 14.15%
2 Healthcare 12.62%
3 Financials 12.54%
4 Industrials 12.05%
5 Consumer Discretionary 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTN
451
CALL
Palatin Technologies
PTN
$13.8M
$504K ﹤0.01%
1,231
AIXC
452
AIxCrypto Holdings Inc
AIXC
$16.7M
$500K ﹤0.01%
3
-2
-40% -$705K
RLJE
453
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$496K ﹤0.01%
200,000
IVTY
454
DELISTED
Invuity, Inc
IVTY
$482K ﹤0.01%
60,690
-88,110
-59% -$643K
NTBL
455
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$458K ﹤0.01%
2,381
TBCH
456
Turtle Beach Corp
TBCH
$277M
$412K ﹤0.01%
113,762
-11,238
-9% -$52.7K
VNCE icon
457
Vince Holding Corp
VNCE
$86.8M
$390K ﹤0.01%
25,160
-41,695
-62% -$999K
TCON
458
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$371K ﹤0.01%
494
-6
-1% -$5.38K
ATXS
459
DELISTED
Astria Therapeutics
ATXS
$354K ﹤0.01%
3,688
-43
-1% -$5.92K
BIOA
460
CALL
DELISTED
BioAmber Inc.
BIOA
$315K ﹤0.01%
135,649
+1
+0% +$4
SQNS
461
Sequans Communications SA
SQNS
$41.3M
$275K ﹤0.01%
1,001
-15,001
-94% -$3.8M
ENSV
462
DELISTED
Enservco Corp.
ENSV
$163K ﹤0.01%
32,460
-11,454
-26% -$85.4K
GEVO icon
463
CALL
Gevo
GEVO
$382M
$110K ﹤0.01%
4,852
+4,609
+1,897% +$195K
ARGS
464
CALL
DELISTED
Argos Therapeutics, Inc.
ARGS
$90K ﹤0.01%
10,000
KALV
465
DELISTED
KalVista Pharmaceuticals
KALV
$88K ﹤0.01%
11,316
-167
-1% -$1.25K
SLS icon
466
CALL
SELLAS Life Sciences
SLS
$2.36B
$48K ﹤0.01%
53
AEO icon
467
American Eagle Outfitters
AEO
$3.01B
-911,000
Closed -$13.8M
AKAM icon
468
Akamai
AKAM
$15.9B
-344,158
Closed -$22.9M
ALLY icon
469
Ally Financial
ALLY
$13.3B
-1,269,437
Closed -$24.1M
ARCT icon
470
Arcturus Therapeutics
ARCT
$211M
-116,359
Closed -$1.71M
ARI
471
Apollo Commercial Real Estate
ARI
$885M
-379,860
Closed -$6.31M
ASC icon
472
Ardmore Shipping
ASC
$683M
-176,678
Closed -$1.31M
ATKR icon
473
Atkore
ATKR
$3.16B
-870,662
Closed -$20.8M
AVT icon
474
Avnet
AVT
$7.92B
-948,676
Closed -$45.2M
AXTA icon
475
Axalta
AXTA
$8.17B
-1,000,000
Closed -$27.2M

Similar funds

Alyeska Investment Group's Q1 2017 Portfolio in Review

As of Q1 2017, Alyeska Investment Group held 627 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group's Q1 2017 filing shows 166 new, 116 increased, 155 reduced and 161 closed positions. Its largest new stake was Agilent Technologies: 2,378,330 shares worth $126M. The largest sale was Cisco, an estimated $141M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Alyeska Investment Group's largest Q1 2017 buy was Agilent Technologies: 2,378,330 shares worth $126M.
  • Alyeska Investment Group added most to Palo Alto Networks in Q1 2017, an estimated $167M increase.
  • Alyeska Investment Group's biggest Q1 2017 reduction was Cisco, cutting an estimated $141M.
  • Alyeska Investment Group fully exited Stryker in Q1 2017, selling an estimated $134M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12.3B portfolio in Q1 2017.
  • Alyeska Investment Group opened 166 new positions and closed 161 in Q1 2017.
  • Alyeska Investment Group's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.